04
Apr
Life Expectancy Hypertrophic Cardiomyopathy. It is chronic genetic heart disease. In this problem cavity present in ones heart stretches and enlarges while compromises the ability of ones heart to do the regular pumping function and get relax appropriately. In some cases sudden cardiac death is the first symptom of the illness. Hypertrophic cardiomyopathy is a heart defect characterized by the increased thickness hypertrophy of the wall of the left ventricle the largest of the four chambers of the heart.
However because there is a very small risk of getting a life-threatening abnormal heart rhythm a small number of people with hypertrophic cardiomyopathy are at risk of sudden cardiac death. Hypertrophic cardiomyopathy life expectancy Research has shown that with proper treatment and follow-up most people with hypertrophic cardiomyopathy live a normal life. However because there is a very small risk of getting a life-threatening abnormal heart rhythm a small number of people with hypertrophic cardiomyopathy are. These features can cause dynamic obstruction of the left ventricular outflow tract diastolic dysfunction myocardial ischaemia and an increased risk of supraventricular and ventricular. Having hypertrophic cardiomyopathy means that the heart muscle myocardium can become excessively thick. This problem takes place often in adult people aging between 20 years and 60 years.
In some cases sudden cardiac death is the first symptom of the illness.
Research has shown that with proper treatment and follow-ups most people with HCM live a normal life. In this problem cavity present in ones heart stretches and enlarges while compromises the ability of ones heart to do the regular pumping function and get relax appropriately. Research has shown that with proper treatment and follow-ups most people with HCM live a normal life. The left ventricle is almost always affected and in some people the muscle of the right ventricle also thickens. Hypertrophic cardiomyopathy HCM is a complex primary and genetic cardiac disease with heterogeneous clinical expression characterized by a benign or stable clinical course over many years progressive congestive heart failure symptoms requiring therapeutic intervention and the possibility of systemic embolic events and sudden unexpected death. The majority of patients with hypertrophic cardiomyopathy have no symptoms and most have a near-normal life expectancy.